Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Financial Officer | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 317,930 |
Ending reported balance
After 2026-05-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-15 · Purchase · Acquired 150,000 · Balance 267,930 F1: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.639 to $0.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1). Row 2 · 2026-05-18 · Purchase · Acquired 50,000 · Balance 317,930 F2: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.627 to $0.639, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2). |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.639 to $0.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1).
F2: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.627 to $0.639, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 19, 2026 20:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | PurchaseCommon Stock | 50,000 | $0.63 | $31,650.00 |
DisclosureSEC source: 0001628280-26-036474 · wk-form4_1779222117.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,930 F2 · price: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.627 to $0.639, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2). Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | PurchaseCommon Stock | 150,000 | $0.65 | $97,350.00 |
DisclosureSEC source: 0001628280-26-036474 · wk-form4_1779222117.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,930 F1 · price: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.639 to $0.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1). Read SEC document |
| January 12, 2026 Filed Jan 16, 2026 21:46 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001730451-26-000006 · wk-form4_1768599964.xml · derivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: 50% of the shares underlying the RSU award will vest on February 1, 2027, with the remaining 50% vesting in equal amounts quarterly over a one-year period through February 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · derivative.expiration_date: 50% of the shares underlying the RSU award will vest on February 1, 2027, with the remaining 50% vesting in equal amounts quarterly over a one-year period through February 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document |
| September 30, 2020 Filed Oct 6, 2020 21:00 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 10,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000270 · wf-form4_160201801959452.xml · derivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested and were delivered on May 25, 2020, 6 months after the Certification. The remaining 25% of shares became fully vested on September 30, 2020 upon the Reporting Person's retirement in accordance with his Separation and Release agreement dated July 28, 2020, but have not yet been delivered. F5 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested and were delivered on May 25, 2020, 6 months after the Certification. The remaining 25% of shares became fully vested on September 30, 2020 upon the Reporting Person's retirement in accordance with his Separation and Release agreement dated July 28, 2020, but have not yet been delivered. Read SEC document |
| September 30, 2020 Filed Oct 6, 2020 21:00 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000270 · wf-form4_160201801959452.xml · derivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: Fully vested upon the Reporting Person's retirement in accordance with the terms of his Separation and Release agreement dated July 28, 2020. The underlying shares of common stock have not been delivered. F4 · derivative.expiration_date: Fully vested upon the Reporting Person's retirement in accordance with the terms of his Separation and Release agreement dated July 28, 2020. The underlying shares of common stock have not been delivered. Read SEC document |
| September 30, 2020 Filed Oct 6, 2020 21:00 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000270 · wf-form4_160201801959452.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. F3 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| September 30, 2020 Filed Oct 6, 2020 21:00 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000270 · wf-form4_160201801959452.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,432 | $81.70 | $116,994.40 |
DisclosureSEC source: 0001666071-20-000257 · wf-form4_159864524471885.xml · nonDerivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,576 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.98, inclusive, Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,049 | $80.81 | $84,769.69 |
DisclosureSEC source: 0001666071-20-000257 · wf-form4_159864524471885.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,008 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $80.50 to $81.48, inclusive. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,502 | $80.10 | $200,410.20 |
DisclosureSEC source: 0001666071-20-000257 · wf-form4_159864524471885.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,057 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $79.50 to $80.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 10,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000257 · wf-form4_159864524471885.xml · derivative · entry 5 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,937 Underlying: Common Stock · 10,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification. F6 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000257 · wf-form4_159864524471885.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 13, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 86 | $79.62 | $6,847.32 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 11 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622 F5 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,769 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 19 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Common Stock · 4,769 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,769 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 18 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 4,769 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,509 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 17 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,509 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 15,047 | $77.14 | $1,160,725.58 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 10 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,708 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.64 to $77.58, inclusive. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 4,769 | $20.00 | $95,380.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 9 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 4,769 | $30.44 | $145,168.36 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 8 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 5,509 | $20.00 | $110,180.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 7 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 700 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 16 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,894 Underlying: Common Stock · 700 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 700 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 15 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,019 Underlying: Common Stock · 700 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 741 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 14 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,509 Underlying: Common Stock · 741 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 13 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F6 · derivative.exercise_date: Fully vested. F6 · derivative.expiration_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · derivative · entry 12 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208 Underlying: Common Stock · 208 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F6 · derivative.exercise_date: Fully vested. F6 · derivative.expiration_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 401 | $76.05 | $30,496.05 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 6 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,708 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.01 to $76.09, inclusive. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 13,019 | $75.55 | $983,585.45 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 5 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 700 | $20.00 | $14,000.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 700 | $30.44 | $21,308.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 741 | $20.00 | $14,820.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 23:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000242 · wf-form4_159736050594990.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| May 27, 2020 Filed May 27, 2020 22:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,512 | $66.98 | $302,213.76 |
DisclosureSEC source: 0001666071-20-000154 · wf-form4_159061721968481.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,479 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on May 25, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $66.40 to $67.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| May 25, 2020 Filed May 27, 2020 22:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 10,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000154 · wf-form4_159061721968481.xml · derivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,874 Underlying: Common Stock · 10,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. F5 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| May 25, 2020 Filed May 27, 2020 22:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 700 | $67.48 | $47,236.00 |
DisclosureSEC source: 0001666071-20-000154 · wf-form4_159061721968481.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on May 25, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.43 to $67.55, inclusive. Read SEC document |
| May 25, 2020 Filed May 27, 2020 22:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000154 · wf-form4_159061721968481.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 150 | $67.77 | $10,165.68 |
DisclosureSEC source: 0001666071-20-000145 · wf-form4_159019692853252.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,053 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000145 · wf-form4_159019692853252.xml · derivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 355 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs are immediately vested. F4 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000145 · wf-form4_159019692853252.xml · derivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355 Underlying: Common Stock · 355 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs are immediately vested. F4 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000145 · wf-form4_159019692853252.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 256 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 800 | $45.46 | $36,368.00 |
DisclosureSEC source: 0001666071-20-000079 · wf-form4_158396895067581.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,592 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on February 26, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $45.08 to $46.01, inclusive. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,046 | $44.48 | $224,446.08 |
DisclosureSEC source: 0001666071-20-000079 · wf-form4_158396895067581.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,392 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on February 26, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $44.06 to $45.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| March 04, 2020 Filed Mar 4, 2020 21:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000058 · wf-form4_158335609709353.xml · derivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. If the Issuer determines to end the Reporting Person's employment before the anniversary date, excluding termination for cause, the RSUs will immediately fully vest on the Reporting Person's final day of employment. F4 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. If the Issuer determines to end the Reporting Person's employment before the anniversary date, excluding termination for cause, the RSUs will immediately fully vest on the Reporting Person's final day of employment. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,310 | $78.80 | $339,628.00 |
DisclosureSEC source: 0001666071-20-000058 · wf-form4_158335609709353.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,438 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F2 · balance_after: Includes 10,938 vested shares which have not been delivered. Read SEC document |
| February 26, 2020 Filed Mar 3, 2020 00:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 10,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000043 · wf-form4_158319559036333.xml · derivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,812 Underlying: Common Stock · 10,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification, and have not yet been delivered. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification. F3 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification, and have not yet been delivered. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| February 26, 2020 Filed Mar 3, 2020 00:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000043 · wf-form4_158319559036333.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares which have not been delivered. F2 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 01:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $98.12 | $294,360.00 |
DisclosureSEC source: 0001666071-20-000029 · wf-form4_158207664228443.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,810 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 17,574 | $84.71 | $1,488,693.54 |
DisclosureSEC source: 0001666071-20-000020 · wf-form4_158085648981466.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,810 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $84.35 to $85.19, inclusive. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,426 | $83.89 | $371,297.14 |
DisclosureSEC source: 0001666071-20-000020 · wf-form4_158085648981466.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,384 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $83.35 to $84.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:40 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,781 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-20-000018 · wf-form4_158025118636869.xml · derivative · entry 11 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,719 Underlying: Common Stock · 25,781 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F9 · derivative.exercise_date: This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:40 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 28,906 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000018 · wf-form4_158025118636869.xml · derivative · entry 10 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,594 Underlying: Common Stock · 28,906 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F8 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.